M&A Deal Summary

Ember Therapeutics Acquires Dermasilk Brands

On September 8, 2016, Ember Therapeutics acquired consumer products company Dermasilk Brands

Acquisition Highlights
  • This is Ember Therapeutics’ 1st transaction in the Consumer Products sector.
  • This is Ember Therapeutics’ 2nd transaction in the United States.
  • This is Ember Therapeutics’ 1st transaction in Connecticut.

M&A Deal Summary
Date 2016-09-08
Target Dermasilk Brands
Sector Consumer Products
Buyer(s) Ember Therapeutics
Deal Type Add-on Acquisition

Target

Dermasilk Brands

Glastonbury, Connecticut, United States
Dermasilk Brands, Inc. is a provider of anti-aging cosmetic products.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Ember Therapeutics

New York, New York, United States
Category Company
Founded 2010
Sector Life Science
DESCRIPTION

Ember Therapeutics, Inc. is a clinical stage biopharmaceutical company whose primary focus is on utilizing Bone Morphogenetic Protein-7 to catalyze cartilage regeneration for disease modification of Osteoarthritis (OA) and the inhibition and reversal of organ fibrosis in diseases such as Chronic Kidney Disease (CKD) and Alport Syndrome.

DEAL STATS #
Overall 2 of 2
Sector (Consumer Products) 1 of 1
Type (Add-on Acquisition) 2 of 2
State (Connecticut) 1 of 1
Country (United States) 2 of 2
Year (2016) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-03-21 Migralex

Greenlawn, New York, United States

Migralex, Inc. is a pharmaceutical company developer of medication for treating pain.

Buy -
Mergr

Product

Company

Legal